Arsad, Shyra B.

HRN: 20-36-65  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2022
CEFUROXIME 1.5GM (VIAL)
06/16/2022
06/16/2022
IVT
1.5g
Loading Dose On Call To OR
G2P1 (1001) Incomplete Abortion For Stat Dilation And Curettage
Waiting Final Action 
06/16/2022
CEFUROXIME 500MG (TAB)
06/16/2022
06/24/2022
PO
500mg
Q12
Post Completion Curettage Prophylaxis
Waiting Final Action 
06/16/2022
METRONIDAZOLE 500MG (TAB)
06/16/2022
06/24/2022
PO
500mg
Q8
Post Completion Curettage Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: